GENOME SEQUENCING OF A CAMELPOX VACCINE REVEALS CLOSE SIMILARITY TO MODIFIED VACCINIA VIRUS ANKARA (MVA)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)

Blog Article

Camelpox is a viral contagious disease of Old-World camelids sustained by Camelpox virus (CMLV).The disease is here characterized by mild, local skin or severe systemic infections and may have a major economic impact due to significant losses in terms of morbidity and mortality, weight loss, and low milk yield.Prevention life extension blueberry extract of camelpox is performed by vaccination.In this study, we investigated the composition of a CMLV-based, live-attenuated commercial vaccine using next-generation sequencing (NGS) technology.

The results of this analysis revealed genomic sequences of Modified Vaccinia virus Ankara (MVA).

Report this page